Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Eur J Haematol. 2017 Mar 28;98(6):529–541. doi: 10.1111/ejh.12870

Figure 3. Schematic of triggered (inducible) nanoparticles in cancer.

Figure 3

Triggered nanoparticles extravasate from the vasculature accumulate in the tumors due to increase EPR effect by biological factors of the tumor microenvironment or external factors (pH, temperature, magnetic field, ultrasound, and light exposure). The release is triggered by those factors into cancer cells (brown).